A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma.
Ray A, Williams MA, Meek SM, Bowen RC, Grossmann KF, Andtbacka RH, Bowles TL, Hyngstrom JR, Leachman SA, Grossman D, Bowen GM, Holmen SL, VanBrocklin MW, Suneja G, Khong HT.
Ray A, et al. Among authors: hyngstrom jr.
Oncotarget. 2016 Sep 27;7(39):64390-64399. doi: 10.18632/oncotarget.10453.
Oncotarget. 2016.
PMID: 27391442
Free PMC article.
Clinical Trial.